The “brain-eating amoeba” is Naegleria fowleri, a single-celled organism that lives in warm freshwater and causes a rapid, almost always fatal brain infection called primary amebic meningoencephalitis (PAM). Infections are extremely rare, but the fatality rate exceeds 97%. Understanding where this organism lives and how it enters the body is the key to prevention.
Where Naegleria Fowleri Lives
Naegleria fowleri thrives in warm freshwater: lakes, rivers, hot springs, and poorly maintained pools. It grows best when water temperatures are high, and infections tend to cluster during prolonged heat waves when water levels drop and temperatures rise. The organism is found naturally in soil and freshwater environments around the world, but it cannot survive in saltwater or in properly chlorinated pools.
While the amoeba has historically been concentrated in southern U.S. states, its geographic range is expanding. A CDC analysis of cases from 1978 to 2018 found that the maximum latitude of exposure locations shifted roughly 13 kilometers northward per year. Five of six Midwest cases occurred after 2010, in states like Minnesota, Kansas, and Indiana. Rising water temperatures in traditionally cooler regions are the likely driver.
How the Infection Happens
Naegleria fowleri infects people when contaminated water is forced up the nose. This typically happens during swimming, diving, or water sports in warm freshwater. The amoeba cannot cause infection if you swallow contaminated water. It needs direct nasal contact.
Once inside the nose, the organism penetrates the nasal tissue and travels along the olfactory nerves, the nerves responsible for your sense of smell, directly into the brain. There it causes massive inflammation and tissue destruction. This pathway from nose to brain is why the infection progresses so quickly and why it’s so difficult to treat. The amoeba essentially has a direct route past the blood-brain barrier.
Symptoms and How Fast It Progresses
The first symptoms usually appear about five days after exposure, though the incubation period can range from one to 12 days. Early signs look a lot like bacterial meningitis or the flu:
- Headache
- Fever
- Nausea and vomiting
This is part of what makes PAM so dangerous. In the early stage, nothing about it screams “rare amoeba infection,” so it’s easily mistaken for something more common. But PAM progresses rapidly. Within days, more severe symptoms develop: stiff neck, confusion, inability to pay attention to people or surroundings, seizures, hallucinations, and coma. Most patients die within one to two weeks of symptom onset.
Why It’s So Hard to Diagnose and Treat
Diagnosing PAM is a race against time, complicated by how rare the infection is. Most emergency physicians will never see a case in their careers. Confirmation requires specialized lab tests available at only a few facilities in the United States, including the CDC. These tests look for the amoeba in cerebrospinal fluid, the liquid surrounding the brain and spinal cord. One method uses genetic testing to identify the organism’s DNA. Others use targeted antibodies or direct microscopic examination of fluid samples.
Treatment involves an aggressive combination of multiple medications, including antifungal and antiparasitic drugs. One key medication, miltefosine, was originally developed to treat a parasitic disease called leishmaniasis and has been used in the handful of patients who survived. Even with the full drug combination, survival is exceptionally rare. The infection destroys brain tissue so quickly that treatment often can’t keep pace, especially when diagnosis is delayed by even a day or two.
How Rare Is It Really?
PAM is one of the rarest infectious diseases tracked in the United States. Roughly zero to eight cases are reported per year. Millions of people swim in warm freshwater every summer without incident. The amoeba is common in the environment, but the specific conditions needed for infection (warm water forced up the nose with enough organisms present) make actual cases exceedingly uncommon.
That said, the fatality rate is devastating. Fewer than five people in the U.S. are known to have survived the infection. This combination of extreme rarity and near-total lethality is what gives Naegleria fowleri its outsized reputation.
Practical Ways to Reduce Your Risk
Since the amoeba can only infect you through the nose, prevention centers on keeping contaminated water out of your nasal passages.
When swimming in warm freshwater, especially in southern states during summer, consider using nose clips or simply keeping your head above water. Avoid stirring up sediment in shallow, warm bodies of water, where the organism is more concentrated. Stay out of warm freshwater that’s stagnant or has low water levels during heat waves.
A less obvious risk comes from nasal rinsing. People who use neti pots or sinus rinse bottles should never use tap water directly. The CDC recommends using water labeled “distilled” or “sterile,” or boiling tap water at a rolling boil for one minute (three minutes above 6,500 feet elevation) and letting it cool before use. If neither option is available, you can disinfect water with unscented household bleach: about four to five drops per quart depending on the bleach concentration, stirred and left to stand for at least 30 minutes. Several PAM cases have been linked to contaminated tap water used in sinus rinses, making this a simple but important precaution.
Properly chlorinated swimming pools and saltwater pose no risk. The amoeba cannot survive in either environment.